NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis MILAN, Dec. 5, 2024 /PRNewswire/ — NTC, an international R&D focused pharmaceutical… CISION PRNewswireDecember 5, 2024
87% of legal industry users say DeepL's Language AI platform helps them work faster, finds new research DeepL unveils new report on the state of AI within the legal… CISION PRNewswireDecember 5, 2024
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing EAST RUTHERFORD, N.J., Dec. 5, 2024 /PRNewswire/ — Cambrex, a leading global contract… CISION PRNewswireDecember 5, 2024
H.I.G. Capital Closes $1 Billion Bayside Loan Opportunity Fund VII MIAMI, Dec. 5, 2024 /PRNewswire/ — H.I.G. Bayside Capital, the special situations credit… CISION PRNewswireDecember 5, 2024
Canadian Solar Reports Third Quarter 2024 Results KITCHENER, ON, Dec. 5, 2024 /PRNewswire/ — Canadian Solar Inc. ("Canadian Solar" or… CISION PRNewswireDecember 5, 2024
Press ReleaseThe 2024 Understanding China Conference (Guangzhou) Took Place GUANGZHOU, China, Dec. 5, 2024 /PRNewswire/ — The 2024 Understanding China Conference… CISION PRNewswireDecember 5, 2024
Press ReleaseAltair and Auburn University to Collaborate on $1.25 Million AFWERX Contract to Advance Vortex Rocket Engines Altair® FlightStream™ to improve engine performance in a fraction of the time… CISION PRNewswireDecember 5, 2024
Press ReleaseCao Thang International Eye Hospital – Marking a footprint on the map of global ophthalmology HO CHI MINH CITY, Vietnam, Dec. 5, 2024 /PRNewswire/ — On November… CISION PRNewswireDecember 5, 2024
